0
0
7/21/25 at 2:00pm
Organization
Seeking Alpha
Author
Wavelength Research
35 words
0
Comments
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on my Strong Buy rating for LLY.
You are the first to view
https://seekingalpha.com/article/4802442-eli-lilly-competition-melts-away
Create an account
or login to join the discussion